DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 132 filers reported holding DEPOMED INC in Q2 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,156,000 | +391.9% | 173,300 | +385.4% | 0.06% | +375.0% |
Q1 2018 | $235,000 | -51.3% | 35,700 | -40.5% | 0.01% | -58.6% |
Q4 2017 | $483,000 | -47.3% | 59,957 | -62.1% | 0.03% | -53.2% |
Q3 2017 | $917,000 | +26.0% | 158,300 | +133.5% | 0.06% | +29.2% |
Q2 2017 | $728,000 | +90.1% | 67,800 | +121.9% | 0.05% | +128.6% |
Q1 2017 | $383,000 | -58.5% | 30,557 | -40.0% | 0.02% | -53.3% |
Q4 2015 | $924,000 | +0.2% | 50,951 | +4.2% | 0.04% | 0.0% |
Q3 2015 | $922,000 | -52.9% | 48,886 | -46.4% | 0.04% | -40.0% |
Q2 2015 | $1,958,000 | +198.9% | 91,254 | +212.1% | 0.08% | +188.5% |
Q1 2015 | $655,000 | +89.9% | 29,239 | +36.5% | 0.03% | +8.3% |
Q4 2014 | $345,000 | +17.7% | 21,428 | +11.2% | 0.02% | +60.0% |
Q3 2014 | $293,000 | +29.6% | 19,265 | +23.8% | 0.02% | -6.2% |
Q1 2014 | $226,000 | +88.3% | 15,565 | +37.6% | 0.02% | +77.8% |
Q4 2013 | $120,000 | – | 11,308 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |